Runben Biotechnology Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 11.29% vs 43.97% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 19.00% vs 24.51% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "267.10",
          "val2": "240.00",
          "chgp": "11.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "49.20",
          "val2": "47.00",
          "chgp": "4.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "2.40",
          "val2": "4.80",
          "chgp": "-50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "52.60",
          "val2": "44.20",
          "chgp": "19.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "184.40%",
          "val2": "171.80%",
          "chgp": "1.26%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 17.25% vs 27.39% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 4.76% vs 32.83% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,534.00",
          "val2": "1,308.30",
          "chgp": "17.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "350.20",
          "val2": "329.40",
          "chgp": "6.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.80",
          "val2": "3.60",
          "chgp": "-77.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "314.50",
          "val2": "300.20",
          "chgp": "4.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "213.80%",
          "val2": "235.50%",
          "chgp": "-2.17%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

267.10

240.00

11.29%

Operating Profit (PBDIT) excl Other Income

49.20

47.00

4.68%

Interest

0.00

0.00

Exceptional Items

2.40

4.80

-50.00%

Consolidate Net Profit

52.60

44.20

19.00%

Operating Profit Margin (Excl OI)

184.40%

171.80%

1.26%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 11.29% vs 43.97% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 19.00% vs 24.51% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,534.00

1,308.30

17.25%

Operating Profit (PBDIT) excl Other Income

350.20

329.40

6.31%

Interest

0.20

0.20

Exceptional Items

0.80

3.60

-77.78%

Consolidate Net Profit

314.50

300.20

4.76%

Operating Profit Margin (Excl OI)

213.80%

235.50%

-2.17%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 17.25% vs 27.39% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 4.76% vs 32.83% in Dec 2024

All Annual Results